| Announce Date | 12/11/2025 |
| EPS Normalized Actual | $0.49 (Miss by $-0.025) |
| EPS GAAP Actual | $0.49 (Miss by $-0.025) |
| Revenue Actual | $0.288331B |
| Revenue Surprise | Beat by $288.331M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Apr 2028 | 2.22634 | 16.03 | 2.22634 | 2.22634 | 1 |
| May 2027 | 2.12077 | 16.82 | 2.12077 | 2.12077 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.5 | 0.5 | 0.288331B | -1% | 288.33M |
| FQ3 2025 (Aug 2025) | 0.6 | 0.6 | 0.330515B | 0.32% | 330.52M |
| FQ2 2025 (May 2025) | 0.48 | 0.48 | 0.313629B | 5.2% | 313.63M |
| FQ1 2025 (Jan 2025) | 0.42 | 0.42 | 0.26705B | -1.13% | 267.05M |
| FQ4 2024 (Oct 2024) | 0.49 | 0.49 | 0.291202B | -3.05% | 291.2M |
| FQ3 2024 (Jul 2024) | 0.61 | 0.61 | 0.329473B | 1.59% | 329.47M |
| FQ2 2024 (Apr 2024) | 0.47 | 0.47 | 0.297315B | 3.57% | 297.32M |
| FQ1 2024 (Jan 2024) | 0.42 | 0.42 | 0.270065B | 0.59% | 270.07M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (May 2028) | 0.50942 | -- | 0.50942 | 0.50942 | 1 |
| FQ1 2028 (Feb 2028) | 0.47063 | -- | 0.47063 | 0.47063 | 1 |
| FQ4 2027 (Nov 2027) | 0.54079 | -- | 0.54079 | 0.54079 | 1 |
| FQ3 2027 (Aug 2027) | 0.63747 | -- | 0.63747 | 0.63747 | 1 |
| FQ2 2027 (Apr 2027) | 0.50597 | -- | 0.50597 | 0.50597 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (May 2028) | 0.31B | -- | 0.31B | 0.31B | 1 |
| FQ1 2028 (Feb 2028) | 0.27B | -- | 0.27B | 0.27B | 1 |
| FQ4 2027 (Nov 2027) | 0.29B | -- | 0.29B | 0.29B | 1 |
| FQ3 2027 (Aug 2027) | 0.34B | -- | 0.34B | 0.34B | 1 |
| FQ2 2027 (Apr 2027) | 0.31B | -- | 0.31B | 0.31B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.5 | 0.5 | 100% | |
| FQ3 2025 (Aug 2025) | 0.6 | 0.6 | 100% | |
| FQ2 2025 (May 2025) | 0.48 | 0.48 | 100% | |
| FQ1 2025 (Jan 2025) | 0.42 | 0.42 | 100% | |
| FQ4 2024 (Oct 2024) | 0.49 | 0.49 | 100% | |
| FQ3 2024 (Jul 2024) | 0.61 | 0.61 | 100% | |
| FQ2 2024 (Apr 2024) | 0.47 | 0.47 | 100% | |
| FQ1 2024 (Jan 2024) | 0.42 | 0.42 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $0.29B | $288.33M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $0.33B | $330.52M | 100% |
| FQ2 2025 (May 2025) | $0B | $0.31B | $313.63M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $0.27B | $267.05M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $0.29B | $291.2M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $0.33B | $329.47M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $0.3B | $297.32M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.27B | $270.07M | 100% |